A Thank You for Your Commitment to Advancing Cancer Research
As we reflect on the past year, I want to thank our investigators, sites, funders, and the entire Hoosier Cancer Research Network team for your continued commitment to investigator-initiated cancer research.
HCRN-GI23-617 to Be Presented at ASCO GI 2026
Jan 8, 2026 An HCRN study, HCRN-GI23-617, will be presented as a Trials in Progress poster at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026 in San Francisco. This study is led by Tiago Biachi de Castria, MD, PHD, of H. Lee Moffitt Cancer Center and Research Institute. Session Details: Poster Session […]
HCRN CEO Brian Stemme featured in BioCentury
We are proud to see our CEO, Brian Stemme, featured in a BioCentury article highlighting Hoosier Cancer Research Network’s role in advancing multi-site investigator-initiated trials (IITs)-
Collaborative Leadership: New HCRN Co-Chairs Unite to Advance Cancer Research
August 12, 2025 Hoosier Cancer Research Network (HCRN) is proud to welcome nine new co-chairs across its clinical trial working groups. These accomplished leaders bring expertise, a dedication to investigator-initiated research, and a shared passion for teamwork that drives discovery forward. Through HCRN, investigators unite to propose clinical trials and share scientific insights. The leadership […]
HCRN-LYM22-565 presented at EHA 2025 Congress
Dipenkumar Modi, MD, of the Karmanos Cancer Institute recently presented an interim analysis of the HCRN-LYM22-565 study at the European Hematology Association (EHA) 2025 Congress, held June 12–15 in Milan, Italy.
ASCO 2025: In Review
Hoosier Cancer Research Network is proud to share a recap of our experience at the 2025 American Society of Clinical Oncology® (ASCO) Annual Meeting. The review features highlights, key photos, notable moments, and insights into how we’re carrying the momentum of ASCO forward. About Hoosier Cancer Research Network: Hoosier Cancer Research Network conducts innovative cancer […]
HCRN’s Report Reveals Key Trends Shaping Investigator-Initiated Oncology Trials
Hoosier Cancer Research Network has released a new report, “Investigator-Initiated Oncology Trials: Trends, Challenges, and Opportunities,” that captures the experience and perspectives of more than 130 researchers across its nationwide network. The findings highlight key trends shaping investigator-initiated oncology research and the operational, institutional, and funding challenges researchers face in today’s environment.
CEO Brian Stemme: A Leader in Life Sciences
We are proud to see our CEO, Brian Stemme, featured in an Indiana Business Journal article as a trusted expert in Indiana’s life sciences ecosystem.
HCRN-LUN21-497 Presented at SITC 2024 Annual Meeting
HCRN investigators presented results from the HCRN-LUN21-497 study as a poster at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting, held November 8–10, 2024, in San Diego, California.
